Consultations by Web site Subject
Here you will find all departmental consultation activities listed by the main subject areas used on this Web site. These are the subjects used throughout the Health Canada Web site to group Health Canada information and are listed here so that you may search under each subject to find the Consultation activities occuring in that subject area.
About Health Canada
Current
Consultative Committee for English-Speaking Minority Communities
This committee has ongoing meetings with Health Canada to assist and advise the Minister of Health on issues relating to the Government of Canada's mandate regarding health to develop English-speaking minority communities and foster their growth.
Past
Consultative Committee for French-Speaking Minority Communities
This committee has ongoing meetings with Health Canada to assist and advise the Minister of Health on issues relating to the Government of Canada's mandate regarding health to develop French-speaking minority communities and foster their growth.
Consumer Product Safety
Current
Consultation on Proposed Regulations for Intentional Ozone Generators
The purpose of this consultation activity is to provide you with information concerning an initiative that relates to the safety of residential intentional ozone generators and to solicit your input with respect to Health Canada's proposal to regulate the output of ozone from these devices to 0.05 ppm.
Proposed Corded Window Covering Products Regulations
This initiative is intended to protect Canadian children against the strangulation hazard posed by corded window coverings.
Consultation with Laser equipment Stakeholders on amendments to the actual Laser Regulations under the Radiation Emitting Devices Act
A summary of the intended changes to the actual obsolete Laser Regulations was sent in the form of a letter to Canadian Laser equipment Stakeholders for comments.
Past
Proposed Lighters Regulations
This initiative proposes to expand the scope of the Regulations to include utility lighters (also known as multipurpose or barbeque lighters) and to update a standard referenced in the Regulations.
Survey of the elementary and high school teachers across Canada who registered to the 2007 Sun Awareness Program
The purposed of the survey is to seek information on the efficacy of the Sun Awareness Program Material and to get information on how it is used and if it has an impact on the students.
Consultation regarding the proposed prohibition of di (2-ethylhexyl) phthalate (DEHP) under the Hazardous Products Act (HPA).
Health Canada's Consumer Product Safety Bureau is proposing to prohibit under the Hazardous Products Act (HPA) the use of di (2-ethylhexyl) phthalate (DEHP) in the plasticised material of toys for children under three years of age and of products for children under three years of age that are likely to be mouthed.
Regulatory Amendment to the Hazardous Products (Kettles) Regulations to Lower Maximum Leachable Lead Level
The proposed change to the Hazardous Products (Kettles) Regulations is being done to harmonize the regulations with the Guidelines for Canadian Drinking Water Quality (SEP, 2004) and also to reduce the Canadian public's exposure to lead as stipulated in the CPSB Lead Risk Reduction Strategy document.
Consultation on Health Canada's Proposal for Legislative Action on Infant Bath Seats and Bath Rings
The purpose of the consultation activity is to solicit feedback from affected parties regarding a proposal to introduce control measures to address the safety of infant bath seats and bath rings that are advertised, sold or imported in Canada.
Proposed Regulatory Amendment to the Cribs and Cradles Regulations and Item 25 of Schedule I to the Hazardous Products Act (HPA)
The purpose of this letter is to provide information concerning an initiative that relates to the safety of cribs, cradles and bassinets, and to solicit input with respect to this proposal.
Consultation on the Draft Guidance on the Classification of Products at the Cosmetic-Drug Interface
Health Canada's draft Guidance on the Classification of Products at the Cosmetic-Drug Interface clarifies how the Department interprets and applies the definitions of cosmetic and drug in the Food and Drugs Act and regulations so that products are regulated using the most appropriate regulatory regime.
Technical Amendments to the Consumer Chemicals and Containers Regulations, 2001 (CCCR, 2001)
Some technical amendments are required to the Consumer Chemicals and Containers Regulations, 2001 (CCCR-2001) to clarify certain requirements and correct a number of editorial errors to ensure that the original intent of the Regulations is maintained.
Consumer and Clinical Radiation Protection Bureau Consultation with Stakeholders on Draft Safety Code for Large Radiological Facilities
Proposed Process for Amending the Cosmetic Ingredient Hotlist
Proposed Amendments to the Hazardous Products (Matches) Regulations
Proposed Technical Amendments to Schedule I to the Hazardous Products Act, the Hazardous Products (Expansion Gates and Expandable Enclosures) Regulations and the Playpens Regulations
Guidelines for Cosmetic Advertising and Labelling Claims
These guidelines are used extensively by both industry and government officials to assess the acceptability of cosmetic claims.
Proposed Regulations Amending the Hazardous Products (Glazed Ceramics and Glassware) Regulations
Stakeholder notification about proposed amendments.
Safety of Corded Window Covering Products
Health Canada is seeking the views of the Canadian public on a proposal that, under the Hazardous Products Act, would put in place legally binding requirements concerning window- covering products that are advertised, sold, or imported into Canada.
Update on proposed Cosmetic Ingredient Labelling Regulations
Health Canada would like to thank everyone who provided comments on the proposed Cosmetic Ingredient Labelling Regulations published in Canada Gazette Part I on March 27, 2004.
Additional information on this consultation:
Drugs and Health Products
Current
Stakeholder Feedback via the Progressive Licensing Framework Website
Health Canada is committed to the modernization of the drug regulatory system. Our vision is a progressive regulatory framework based on sound science and risk management that supports timely access to promising new pharmaceuticals and biologics.
Veterinary Drugs Directorate's consultation with stakeholders on the proposed draft definition of a Veterinary Natural Health Product
The Veterinary Drugs Directorate (VDD) plans to launch a three month web-based consultation on the draft definition of Veterinary Natural Health Products (vNHP) beginning August 3, 2007, as a necessary step in the development of an appropriate regulatory framework for vNHPs.
Health Products and Food Branch Consultations on Cost Recovery Framework
The Health Products and Food Branch is consulting on its revised cost recovery framework, which covers fees for the regulation, licencing, and post market surveillance of drugs, medical devices and natural health products.
Past
Health Canada Consultation on Proposed Changes to the Regulatory Framework for Investigational Testing of Medical Devices
Health Canada is considering a number of amendments to the Medical Device Regulations in order to strengthen its risk management approach for investigational testing and support its interest in applying a risk management approach that is consistent with the approaches applied by other regulators, including the regulatory framework that Health Canada applies for clinical trials of drugs.
Inspection Strategy for Blood and Source Plasma Establishments (POL-0039)
This policy describes the Health Products and Food Branch Inspectorate approach to planning the cycles of GMP inspections in relation to issuance of the Blood Establishment Licences (EL).
Draft Guidance Document - Triggers for Issuance of Risk Communication Documents for Marketed Health Products for Human Use
The Triggers for Issuance of Risk Communication Documents for Marketed Health Products for Human Use describes situations where Health Canada and/or the Market Authorization Holders (MAHs) consider the dissemination of risk communication documents.
Health Products and Food Branch Official Notice of Fee Proposal
The Health Products and Food Branch has posted its proposed revised cost recovery framework, which covers fees for the regulation, licensing and post-market surveillance of drugs and medical devices.
On-line Consultation on the Proposed Regulatory Framework for Whole Blood and Blood Components
Health Canada intends to consult with stakeholders in order to discuss and receive feedback on the proposed regulatory framework for whole blood and blood components.
Consultation on the Draft Guidance on the Classification of Products at the Cosmetic-Drug Interface
Health Canada's draft Guidance on the Classification of Products at the Cosmetic-Drug Interface clarifies how the Department interprets and applies the definitions of cosmetic and drug in the Food and Drugs Act and regulations so that products are regulated using the most appropriate regulatory regime.
Drug Analysis Service Client Service Consultation with Law Enforcement in Ontario
Drug Analysis Service in Ontario Region will be inviting key Law Enforcement colleagues to discuss ongoing service delivery standards.
Public Consultation - Natural Health Products Regulatory Review
Health Canada is undertaking a review of regulatory issues which have been identified over the three years since implementation of the Natural Health Products Regulations. The review is intended to guide the process for the refinement of the regulation of natural health products in Canada.
E-consultation on Health Canada's "Blueprint for Renewal: Transforming Canada's Approach to Regulating Health Products and Food"Health Canada's Health Products and Food Branch (HPFB) has developed a 'Blueprint for Renewal' - a plan for modernizing and creating a more responsive regulatory system for health products and food. more...
Policy on Public Input into the Review of Health Products
Review of Health Canada's Regulatory Framework for Clinical Trials
Public Forum on Breast Implants
Health Canada is currently reviewing the license applications of silicone gel-filled breast implants in Canada, with public input being an integral part of the Department's decision-making process. Health Canada has initiated a public forum to be held September 29-30, 2005 as part of its process for assessing the safety, risks, and benefits of silicone gel-filled breast implants.
Expert Advisory Panel Report
Development of Risk Management Strategy for Antimicrobial Resistance -- Consultation with Stakeholders
Focus on the report of Health Canada Advisory Committee on Animal Uses of Antimicrobials and Impact on Resistance and Human Health.
Draft Guidance for Industry on Management of Regulatory Submissions
The purpose of this document is to clarify the requirements for key steps in the process and enable drug sponsors to improve the quality of their submissions.
Draft Guidance for Industry on Preparation of Veterinary New Drug Submissions
The purpose of this document is to provide guidance for the preparation of a well-structured veterinary drug submission.
Draft Guidance for Industry -- Pharmaceutical Quality of Inhalation and Nasal Products
This document is intended to provide guidance to industry on the pharmaceutical quality of inhalation and nasal products to be authorized for marketing in Canada and/or in the European Union.
Consultation on proposed regulatory standards for e-prescribing in Canada
Health Protection Legislation Renewal -- Veterinary Drugs Discussion Document
A comprehensive review of the health protection system aimed at replacing outdated federal statutes that were developed decades ago in a piecemeal fashion.
Available Report
Measures to help ensure Canadians' continued access to an adequate supply of safe and affordable drugs (Internet Consultation)
Minister Dosanjh is reaffirming Health Canada's commitment to the health and safety of Canadians and Canada's drug system by proposing three measures to help protect Canada's drug supply and enhance consumer safety.
Maximum Residue Limits
Establishing Maximum Residue Limits (MRLS) for Altrenogest
Ongoing consultations to obtain feedback from stakeholders on proposed MRLs for Altrenogest. Feedback will be used for the promulgation of MRLs.
MedEffect Web site Consultations
To gather key stakeholder input for the development of the MedEffect portal, which allows centralized access to new safety information about marketed health products.
Options Analysis Paper will launch the stakeholder consultation process to provide input on which of three regulatory options and related arrangements stakeholders prefer
Proposal for Ceftiofur
Proposal for Danofloxacin
Proposal for Diclazuril
Proposal for Doramectin
Proposal for Enrofloxacin
Proposal for Eprinomectin
Proposal for Florfenicol
Proposal for Flunixin
Proposal for Ketoprofen (December 5, 2003)
Proposal for Ketoprofen (January 24, 2005)
Proposal for Lincomycin
Proposal for Melengestrol Acetate (MGA)
Proposal for Monensin
Proposal for Narasin
Proposal for Oxytetracycline
Proposal for Pirlimycin
Public Involvement Policy of the Veterinary Drugs Directorate (VDD)
VDD's strategic objective is to create an open, transparent, leading-edge, proactive organization that will enable its stakeholders, partners and the public to understand and contribute to VDD's priorities, capacity and performance while also contributing to VDD's statutory responsibilities as a regulator.
Consultations on the Registration and Disclosure of Clinical Trial Information
The feedback received will be used to help develop options for facilitating the registration and disclosure of clinical trial information.
Reprocessing of Single Use Medical Devices (SUDs)
Health Canada is currently undertaking consultations to develop a pan-Canadian strategy to manage the risks associated with the re-use of single-use medical devices.
Strengthening the Evaluation of Real World Drug Safety and Effectiveness
This working conference explores how to enhance the evaluation of the safety and effectiveness of drugs that are on the market. The conference will bring together federal, provincial and territorial officials, health care providers, patient representatives, the pharmaceutical industry and researchers.
Stakeholder's Workshop on the Review of Section 29.16 of the New Substance Notification Regulations (NSNRs)
The purpose of the activity is to engage and seek the views of interested parties on issues surrounding the effectiveness of s.29.16 of the NSNRs in protecting human health and the environment, and possible options to address them.
Selective COX-2 drugs: Expert Advisory Panel meeting and Public Forum
The Expert Advisory Panel on selective COX-2 non-steroidal anti-inflammatory drugs met in Ottawa on June 9 and 10, 2005. The first day consisted of a Public Forum where for the first time members of the public could present to a Health Canada expert panel. The second day was held in camera.
VICH Consultations
VICH is a trilateral (EU-Japan-USA) program aimed at harmonizing technical requirements for veterinary product registration.
Consultations -- Veterinary Drugs Directorate's Animal Tissue Form
Health Canada is seeking your comments on the development of an Animal Tissue Form that requests information on animal-sourced material used in the manufacture veterinary drugs.
Second Round of External Stakeholder Consultations
Revised Draft Consumer Advertising Guidelines for Marketed Health Products (for Nonprescription Drugs including Natural Health Products)
Invitational Roundtable -- Risk Information Communication (Section 2.21) of the Revised Draft Consumer Advertising Guidelines for Marketed Health Products
Environmental and Workplace Health
Current
Stakeholder consultation on scientific criteria document for elemental mercury (Hg0)
To engage selected stakeholders for review of Health Canada draft document Scientific Criteria Document for Mercury Vapour (Hg0): Establishing a Reference Exposure Level (REL) for Risk Assessment for Hg0 Exposures in Canada and solicit their written comments.
Federal-Provincial-Territorial Committee on Drinking Water: Guideline Technical Document on Chlorine in Drinking Water for public comment
Health Canada, as secretariat to the Federal-Provincial-Territorial Committee on Drinking Water is posting the Guideline Technical Document on Chlorine in Drinking Water for a 2-month consultation process.
Past
Canadian Guidelines for Household Reclaimed Water for Use in Toilet and Urinal Flushing - Draft Document for Consultation
Health Canada, on behalf of the Committee on the Health and Environment (CHE), is posting the Canadian Guidelines for Household Reclaimed Water for Use in Toilet and Urinal Flushing for a 3-month consultation period.
Federal-Provincial-Territorial Committee on Drinking Water: Guideline Technical Document on benzene in Drinking Water for public comment
Health Canada, as secretariat to the Federal-Provincial-Territorial Committee on Drinking Water is posting the Guideline Technical Document on benzene in Drinking Water for a 2-month consultation process.
Federal-Provincial-Territorial Committee on Drinking Water: Guideline Technical Document Corrosion Control in Drinking Water Distribution Systems for public comment
Health Canada, as secretariat to the Federal-Provincial-Territorial Committee on Drinking Water is posting the Guideline Technical Document on Corrosion Control in Drinking Water Distribution Systems for a 3-month consultation process.
Federal-Provincial-Territorial Committee on Drinking Water: Guideline Technical Document on Potassium in Drinking Water for public comment
Health Canada, as secretariat to the Federal-Provincial-Territorial Committee on Drinking Water is posting the Guideline Technical Document on Potassium in Drinking Water for a 3-month consultation process, ending on May 31, 2007.
Canadian Workshop on Bioaccesssibility/Bioavailability in Contaminated Site Assessment - an Industry Perspective
To facilitate information exchange between Health Canada Contaminated Sites Program personnel and key industry scientists who have to deal with contaminated lands that industry owns, who are directly involved in either research in bioaccessibility/bioavailability, or who are active in contaminated site risk assessments
Consultations with Targeted Stakeholders on National Guidelines for Environmental Assessment: Health Impacts of Noise.
Health Canada is developing national guidelines on this topic. The purpose of the March 31, 2006 consultation activity is to obtain input from targeted stakeholders on the working group's first draft.
Federal-Provincial-Territorial Committee on Drinking Water: Guideline Technical Document on Chloral Hydrate in Drinking Water for public comment.
Health Canada, as secretariat to the Federal-Provincial-Territorial Committee on Drinking Water is posting the Guideline Technical Document on chloral hydrate in Drinking Water for a 2-month consultation process.
Haloacetic Acids in Drinking Water
The purpose of this consultation is to solicit comments on a proposed guideline, on the approach used for its development and on the potential economic costs of implementing it, as well as to determine the availability of additional exposure data.
Proposal on Integrated Framework for Health-Related Components of CEPA DSL Categorization
To inform and obtain comment from stakeholder and general public regarding proposal content and options listed leading to an integrated Framework for Health-related Components of DSL Categorization.
Proposed guideline for moulds in residential indoor air
On December 23, 2006, Health Canada published in Canada Gazette, Part I a proposed guideline on mould in residential indoor air.
Radiological Characteristics of Drinking Water
For the past several years, the Federal-Provincial-Territorial Committee on Drinking Water (CDW) has been assessing the available information on radiological characteristics of drinking water with the intent of revising the existing guidelines for radionuclides in drinking water.
First Nations and Inuit Health
Past
Development of Health Integration Plan with stakeholders on Aboriginal Health Transition Fund (AHTF)
Regional
Strategic Plan on Aboriginal Health
Food and Nutrition
Current
Consultation on Draft Guidance Document: Food Directorate's Management of Pre-Market Submissions
In line with Health Canada's Regulatory Modernization Strategy for Food and Nutrition Initiative, the Food Directorate is reviewing its approach to pre-market reviews of novel food, food additive, and infant formula submissions with the aim of improving timeliness, predictability, transparency and responsiveness.
Past
VITALITY: Community Use of A Guide for Leaders
To identify the degree to which leaders of community healthy weights programs are using, and have used, A Guide for Leaders, to help determine the next steps for this guide.
A Consultation with Stakeholders on the Recommended Guidelines for Management of the Risks Related to the Consumption of Donairs and Similar Products (Gyros, Kebabs, Chawarmas and Shawarmas)
Donairs have been linked to three separate outbreaks of E. coli O157:H7 in Canada since 2004, with a total of approximately 100 confirmed or suspected cases of foodborne illness.
Food Directorate consultation with stakeholders on a revised guideline for management of health risks associated with raw ground beef products found positive for Escherichia coli O157:H7 or O157 non-motile (Guideline #10).
Health Canada has revised their Guideline on ground beef products found positive for Escherichia coli O157. The updated guideline will assist the beef industry and inspection/enforcement officers in assessing the risks due to E. coli O157 and interventions to protect the public.
Online Consultation on Canada's Food Guide Revision
As part of Health Canada's ongoing efforts to consult Canadians on the proposed content of the revised Food Guide, an online consultation will be conducted from February 15, 2006 to March 24, 2006.
Addition of Vitamins and Minerals Policy Review and Implementation
This document is designed to help you provide us with your comments and, ultimately, influence the development of new regulations on addition of vitamins and minerals to foods for Canada.
Available Reports: Report 1, Report 2, Report 3
Dietary Guidance
To provide an update on proposed directions for national dietary guidance such as Nutrition Recommendations for Canadians, Canada's Guidelines for Healthy Eating and Canada's Food Guide to Healthy Eating.
2002 Consultations on Food Directorate Priorities and Actions
Natural Health Products Directorate (NHPD) Consultation on Fatty Acids and Essential Fatty Acids (EFAs)
Guidelines for the Safety Assessment of Novel Foods Derived from Plants and Microorganisms
These guidelines define the criteria and basic information requirements that must be considered in assessing the safety of novel whole foods and food constituents.
Health Canada's Food Directorate Regional Stakeholder Forum in Vancouver
Gain a better understanding of priority food safety and nutrition issues in the Western Region and what improvements may be required to the regulatory framework to better address those issues.
Labelling of Unpasteurized Fruit Juice / Cider
Thank you for participating in the consultation. The session closed on December 16, 2005 and Health Canada is now analyzing the responses. A summary of the analysis will be posted in Spring 2006, along with the next steps.
Multi-stakeholder Task Force on Trans Fat
Health Canada, in conjunction with the Heart and Stroke Foundation of Canada, works through a multi-stakeholder task force to develop recommendations and strategies for reducing trans fats in Canadian foods to the lowest level possible.
Natural Health Products Directorate (NHPD) Consultation on Fatty Acids and Essential Fatty Acids (EFAs)
In March 2005, the NHPD commissioned a discussion paper that focused on Canadian fatty acid and EFA research and issues related to conducting fatty acid and EFA research in Canada.
Revision of Health Canada's Guidelines for the Safety Assessment of Novel Foods
The present consultation is intended to solicit comments on the revised Guidelines for the Safety Assessment of Novel Foods Derived from Plants and Microorganisms and on several issues related to the regulation of novel foods in Canada.
Healthy Living
Past
Proposed regulations to prohibit "light" and "mild" terms under the Tobacco Act
Health Canada is proposing regulations pursuant to the Tobacco Act, that would prohibit the use of the terms "light" and "mild", variations in their spelling, abbreviations and modifiers of those terms.
Consultation on the reimbursement of expenditures under the Assisted Human Reproduction Act
The purpose of this document is to seek input from stakeholders on options for the regulation of reimbursement of expenditures under the Assisted Human Reproduction Act (AHR Act).
Consultations on Tobacco cessation/control/prevention with Francophone Stakeholders in Ontario
To determine the gaps and needs of Francophone population and stakeholders with regards to tobacco use prevention/cessation/control, Health Canada staff in Ontario will meet with NGOs and the general public. This consultation will provide insight into the needs of the target population in St-Catharines, London, Toronto, Thunder Bay, Kapuskasing, Sudbury, North Bay, Ottawa and Alexandria.
Consultation on the health issues facing Canada's Children and Youth
The Honourable Tony Clement, Minister of Health has appointed Dr. Khristinn Kellie Leitch as his Advisor on Healthy Children and Youth. In this role, Dr. Leitch will make recommendations regarding ways in which the federal government can better contribute to enhancing the health of children and youth.
Consultations on Tobacco Use with Urban Aboriginal Organizations and Urban Aboriginal Youth
To determine the gaps and needs of urban Aboriginal people with regards to tobacco use prevention/cessation/control, Health Canada staff in Ontario will meet with most of the urban Aboriginal organizations.
Counselling Services Under the AHR Act
The purpose of this document is to seek input from stakeholders on options for the regulation of counselling services under the Assisted Human Reproduction Act (AHR Act).
Public Consultation on a proposed mental health commission and federal priorities on mental health and mental illness
Mental illness is a significant public health challenge affecting the lives of many Canadians, and impacting both the economic and social development of the country and the population. Mental health and mental illness have also been characterized as long-neglected areas of health and social policy.
Proposal to Regulate the Retail Display and Promotion of Tobacco and Tobacco-Related Products
Health Canada has prepared a consultation document to seek input from the public regarding possible regulations to restrict at retail the display of tobacco products and accessories that carry tobacco product brand names or logos as well as signs on availability and price.
Licensing and Regulation of Controlled Activities under the AHR Act & Obligations of Licensees Regarding Health Reporting Information
Consultations with assisted human reproduction clinics to further development of regulations in support of the Assisted Human Reproduction Act.
Consultations with Stakeholders on Phase Two of the Federal Tobacco Control Strategy
Health Canada's Tobacco Control Programme invites stakeholders engaged in tobacco control issues in Canada to share their views concerning the second phase of the Federal Tobacco Control Strategy (FTCS).
Consultations with Tobacco C essation Quitline Stakeholders on a Proposed Minimum Dataset for Evaluation
Health Canada is proposing that all Canadian smoking cessation quitlines collect the same evaluation data for all callers.
Proposal for New Health-related Information on Tobacco Product Labels
Consultation Paper
Proposal to Amend the Contraventions Regulations with Respect to the Tobacco Act
Health Canada is proposing changes to Schedule XIV of the Contraventions Regulations to add offences under eight new provisions of the Tobacco Act found in Part I (tobacco products), III (labelling) and IV (promotion). The Contraventions Act establishes a simplified procedure for prosecuting certain federal offences.
Proposed regulations for the renewal of Health-related Information on Tobacco Product Labels under the Tobacco Act
Due to the recent federal election, this consultation has been suspended. This site will be updated as further information becomes available.
Proposed regulations to prohibit "light" and "mild" descriptors under the Tobacco Act
Due to the recent federal election, this consultation has been suspended. This site will be updated as further information becomes available.
Proposed regulatory amendment to the Tobacco Access Regulations
Due to the recent federal election, this consultation has been suspended. This site will be updated as further information becomes available.
Regional Discussions on the National Youth and Young Adult Framework for Action on Tobacco Control
Health Canada is working with the Provinces and Territories to develop a Youth and Young Adult Framework on Tobacco Control. This Framework will set out a long-term plan to help address the issue of tobacco use for people under thirty years of age.
Regulatory Proposal To Include Warnings in Tobacco Advertisements
Consultation Paper
Available Report
Request for comments on an issues paper regarding pre-implantation genetic diagnosis (PGD)
Science and Research
Current
Online consultation with external stakeholders on the identification of Health Canada science needs for the Health Canada Science and Technology Strategy
As a central element in the development of the Health Canada Science & Technology Strategy, the department is consulting a wide range of external stakeholders regarding its science needs.
|
